BORTEZOMIB JN bortezomib 3.5 mg powder for injection vial Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

bortezomib jn bortezomib 3.5 mg powder for injection vial

juno pharmaceuticals pty ltd - bortezomib, quantity: 3.5 mg - injection, powder for - excipient ingredients: nitrogen; mannitol - bortezomib jn (bortezomib 1 mg and 3.5 mg powder for injection), in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,bortezomib jn (bortezomib 1 mg and 3.5 mg powder for injection), as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,bortezomib jn (bortezomib 1 mg and 3.5 mg powder for injection) is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.,bortezomib jn (bortezomib 1 mg and 3.5 mg powder for injection) in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Bortezomib Teva Pdr for Soln for Injection 3.5mg/vial Malta - angleščina - Malta Medicines Authority

bortezomib teva pdr for soln for injection 3.5mg/vial

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - bortezomib - powder for solution for injection - bortezomib 3.5 mg - antineoplastic agents

Bortezomib Teva 2.5mg powder for solution for injection Irska - angleščina - HPRA (Health Products Regulatory Authority)

bortezomib teva 2.5mg powder for solution for injection

teva b.v. - bortezomib - powder for solution for injection - 2.5 milligram(s) - bortezomib

Bortezomib Krka 1 mg powder for solution for injection Irska - angleščina - HPRA (Health Products Regulatory Authority)

bortezomib krka 1 mg powder for solution for injection

krka, d.d., novo mesto - bortezomib - powder for solution for injection - 1 milligram(s) - bortezomib

Bortezomib Krka 3.5 mg powder for solution for injection Irska - angleščina - HPRA (Health Products Regulatory Authority)

bortezomib krka 3.5 mg powder for solution for injection

krka, d.d., novo mesto - bortezomib - powder for solution for injection - 3.5 milligram(s) - bortezomib

Bortezomib Clonmel 2.5 mg/ml solution for injection (1.4ml vial) Malta - angleščina - Malta Medicines Authority

bortezomib clonmel 2.5 mg/ml solution for injection (1.4ml vial)

clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - bortezomib - solution for injection - bortezomib 3.5 mg - antineoplastic agents

Bortezomib 3.5mg powder for solution for injection Malta - angleščina - Malta Medicines Authority

bortezomib 3.5mg powder for solution for injection

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - bortezomib - powder for solution for injection - bortezomib 3.5 mg - antineoplastic agents

Bortezomib 3.5 mg powder for solution for injection Irska - angleščina - HPRA (Health Products Regulatory Authority)

bortezomib 3.5 mg powder for solution for injection

baxter holding b.v. - bortezomib - powder for solution for injection - bortezomib

Bortezomib Actavis 3.5mg powder for solution for injection Malta - angleščina - Malta Medicines Authority

bortezomib actavis 3.5mg powder for solution for injection

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - bortezomib - powder for solution for injection - bortezomib 3.5 mg - antineoplastic agents